{"id":929,"name":"Hatch Bio Fund","slug":"hatch-bio-fund","website":"https://www.hatchbiofund.com/","hqGeo":"San Diego, CA","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Healthcare","Other","SaaS"],"excludedSectors":[],"checkSizeMin":500000,"checkSizeMax":3000000,"thesisSummary":"Focuses on early-stage biotech companies transforming health through innovative technology.","thesisNarrative":null,"logoUrl":null,"aumUsd":50000000,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"翰长生物医疗（深圳）有限公司","companyUrl":null,"stage":null,"sector":"Healthcare","investmentYear":2017,"description":"致力于通过人工智能、远程诊断和医疗技术，与全球专业健康服务者一起，共同提升人类健康水平。","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"翰长生物医疗（深圳）有限公司","companyUrl":null,"stage":"Established","sector":"Healthcare","investmentYear":2017,"description":"致力于通过人工智能、远程诊断和医疗技术，与全球专业健康服务者一起，共同提升人类健康水平。","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Vittoria Biotherapeutics, Inc.","companyUrl":null,"stage":"Clinical-stage (early, with 5-day manufacturing)","sector":"Biotechnology (Cell Therapy)","investmentYear":null,"description":"Clinical-stage immunotherapy company developing novel CAR T cell therapies using the Senza5™ platform for solid tumors and autoimmune diseases, licensed from University of Pennsylvania.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Latus Bio","companyUrl":null,"stage":"Pre-clinical/early-stage","sector":"Biotechnology (Gene Therapy)","investmentYear":null,"description":"Patient-centric gene therapy company developing proprietary AAV capsids screened in non-human primates for clinical administration, founded from Professor Beverly Davidson's lab.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"MasterSwitch Bio","companyUrl":null,"stage":"Pre-clinical/early-stage","sector":"Biotechnology (mRNA Therapeutics)","investmentYear":null,"description":"Joint spinout from University of Pittsburgh and University of Pennsylvania developing modified mRNA therapy targeting HNF4α for End Stage Liver Disease with cirrhosis; co-founded by Nobel laureate Dr. Drew Weissman.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ladder Bio (formerly ThirdLaw Molecular)","companyUrl":null,"stage":"Pre-clinical/early-stage","sector":"Biotechnology (Drug Discovery Platform)","investmentYear":null,"description":"Spinout from Temple University creating synthetic Spiroligomers™—orally available, cell-permeable peptide-like molecules—for selective protein binding across diverse targets.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Hula Therapeutics","companyUrl":null,"stage":"Preclinical / early clinical discovery stage","sector":"Immunotherapy / antigen discovery / engineered T cell or similar","investmentYear":null,"description":"Immunotherapy spin-out from Children’s Hospital of Philadelphia; identifies tumor-essential, HLA-presented targets that are considered “undruggable” and engineers therapies to improve safety & efficacy in solid tumors.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Helix","companyUrl":null,"stage":null,"sector":"Genomic Testing","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ladder Bio","companyUrl":null,"stage":"Preclinical / discovery stage","sector":"Small molecule / peptide-mimetic / synthetic biologics","investmentYear":null,"description":"Spin-out from Temple University; developed a synthetic, modular, fused-ring peptide-like platform (“Spiroligomers™”) that is cell-permeable & orally bioavailable to engage challenging protein targets; billions of library members.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Genome Medical","companyUrl":null,"stage":null,"sector":"Genomic Medicine","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":4,"partners":[{"id":11530,"name":"Lorenzo Pellegrini, Ph.D.","title":"Managing Partner","seniority":null,"focusTags":["life sciences","translational research","early-stage biotech"],"linkedinUrl":"https://www.linkedin.com/in/lorenzo-pellegrini","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":11532,"name":"Timothy M. Block, Ph.D.","title":"Founder and Advisor","seniority":null,"focusTags":["virology","hepatitis research","infectious disease therapeutics"],"linkedinUrl":"https://www.linkedin.com/in/timothy-m-block","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":1428,"name":"Michael Kresmer","title":"Founding Partner","seniority":null,"focusTags":["Biotech","Personalized Medicine"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":11531,"name":"Louis P. Kassa III, MPA","title":"Founder and Advisor","seniority":null,"focusTags":["biotechnology entrepreneurship","incubators","non-profit partnerships"],"linkedinUrl":"https://www.linkedin.com/in/louis-p-kassa-iii","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":2017,"investmentsLast12Months":0},"investorType":"vc","preferredApproach":"cold outreach ok","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":4965,"name":"Perennial Edge Ventures","slug":"perennial-edge-ventures","logoUrl":null,"website":"https://perennialedge.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Other","SaaS"],"hqGeo":"Boston, MA"},{"id":547,"name":"Cocoa VC","slug":"cocoa-vc","logoUrl":null,"website":"https://www.cocoa.vc/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Fintech","SaaS","Other"],"hqGeo":"San Francisco, CA"},{"id":6492,"name":"Breed Reply","slug":"breed-reply","logoUrl":null,"website":"https://www.reply.com/","stageFocus":[],"sectorTags":["Healthcare","Security"],"hqGeo":null},{"id":4903,"name":"Latency Ventures","slug":"latency-ventures","logoUrl":null,"website":null,"stageFocus":["Pre-Seed","Seed"],"sectorTags":["Other","Enterprise","SaaS"],"hqGeo":"Denver, CO"},{"id":2213,"name":"Sport Infinity Ventures","slug":"sport-infinity-ventures","logoUrl":null,"website":"https://www.infinitycapital.bh/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Other","SaaS","Fintech"],"hqGeo":"London, UK"},{"id":6827,"name":"Force Over Mass","slug":"force-over-mass","logoUrl":null,"website":"https://www.fomcap.com/","stageFocus":[],"sectorTags":["AI / ML","Developer Tools","Other","Fintech","SaaS","Healthcare","EdTech"],"hqGeo":null}],"featuredIn":[{"slug":"pre-seed","displayName":"Pre-Seed Investors","pageType":"stage"},{"slug":"saas","displayName":"SaaS Investors","pageType":"industry"},{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"find-right-pre-seed-investors-b2b-saas","title":"How to Find the Right Pre-Seed Investors for Your B2B SaaS Startup"},{"slug":"Finding-Investors-For-Startup-In-2026","title":"How to Find Investors for Your Startup in 2026 (Without Cold-Searching Databases)"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-07-15T08:42:43.091Z"}